These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1378351)

  • 1. Possibilities for active immunotherapy of human cancer.
    Hellström KE; Hellström I
    Cancer Invest; 1992; 10(4):285-93. PubMed ID: 1378351
    [No Abstract]   [Full Text] [Related]  

  • 2. Oncogene-associated tumor antigens as targets for immunotherapy.
    Hellström KE; Hellström I
    FASEB J; 1989 Apr; 3(6):1715-22. PubMed ID: 2649402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic tumor vaccines.
    Hellström KE; Hellström I
    Int Rev Immunol; 1989; 4(4):337-46. PubMed ID: 2519931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].
    Gaugler B; Olive D
    Pathol Biol (Paris); 1998 Dec; 46(10):771-8. PubMed ID: 9922993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytotoxic T-cell immune response against melanoma antigens].
    Ayyoub M
    Ann Dermatol Venereol; 1998 Nov; 125 Suppl 2():S34-6. PubMed ID: 9922891
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour immunology: a review.
    Lachmann PJ
    J R Soc Med; 1984 Dec; 77(12):1023-9. PubMed ID: 6439868
    [No Abstract]   [Full Text] [Related]  

  • 7. Active immunotherapy against cancer: present status.
    Morton DL
    Semin Oncol; 1986 Jun; 13(2):180-5. PubMed ID: 3520826
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor immunology.
    Naftzger C; Houghton AN
    Curr Opin Oncol; 1991 Feb; 3(1):93-9. PubMed ID: 2043699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunotherapy with MAGE antigens.
    Coulie PG
    Suppl Tumori; 2002; 1(4):S63-5. PubMed ID: 12415826
    [No Abstract]   [Full Text] [Related]  

  • 10. Toward a genetic analysis of tumor rejection antigens.
    Boon T
    Adv Cancer Res; 1992; 58():177-210. PubMed ID: 1546558
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-specific antigens of mouse tumors.
    DeLeo AB
    J Immunother (1991); 1992 Oct; 12(3):194-5. PubMed ID: 1445810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy.
    Krishnadas DK; Wang Y; Sundaram K; Bai F; Lucas KG
    Tumour Biol; 2017 Jul; 39(7):1010428317701309. PubMed ID: 28677424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A commentary on the first international conference on engineered vaccines for cancer and AIDS; the "coming of age" of tumor immunology.
    Ada G
    Cancer Biother; 1994; 9(1):71-4. PubMed ID: 7529084
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour immunology: the end of the beginning.
    Hall JG
    Practitioner; 1982 Dec; 226(1374):2010-20. PubMed ID: 7170295
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.
    Boon T
    Int J Cancer; 1993 May; 54(2):177-80. PubMed ID: 8486420
    [No Abstract]   [Full Text] [Related]  

  • 16. Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
    Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T
    Biochem Soc Trans; 1995 Aug; 23(3):681-6. PubMed ID: 8566443
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation of the melanoma-associated antigen p23 using antibody phage display.
    Li J; Pereira S; Van Belle P; Tsui P; Elder D; Speicher D; Deen K; Linnenbach A; Somasundaram R; Swoboda R; Herlyn D
    J Immunol; 2001 Jan; 166(1):432-8. PubMed ID: 11123321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human tumor vaccines go molecular. Summary of American Association for Cancer Research Symposium, March 20,1995.
    Berd D; Parmiani G
    Cancer Immunol Immunother; 1995 Sep; 41(3):199-200. PubMed ID: 7553690
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential of melanoma antigen expression in cancer therapy.
    Gillespie AM; Coleman RE
    Cancer Treat Rev; 1999 Aug; 25(4):219-27. PubMed ID: 10448130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
    Fang JB; Wang L
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.